Abnormal expression of microRNAs (miRNAs) in cancer suggests their applicability as diagnostic and prognostic signatures. Here we describe a new microarray platform, miRCURY™ LNA, based on Locked ...

In several recent publications the term ‘molecular karyotyping’ was adopted to describe the use of microarrays for detecting genomic imbalances, in analogy to conventional karyotyping based on ...

The factors that drive growth of the global microarray market include increase in number of on-going research and development activities, increase in government support for research and development ...

A method of analyzing DNA microarray data based on the physical modeling of hybridization is presented. We demonstrate, in experimental data, a correlation between observed hybridization intensity and ...

Table 9: Global Microarray Analysis Market, by End User, $Million Table 10: Global Microarray Analysis Market (by Product), $Million, 2022-2033 Table 11: Global ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

The market for microarray analysis has reached a mature phase and is on a strong growth path, driven by increasing demand for precision medicine and progress in genetic and genomic studies. It ...

In several fields including environmental monitoring, food manufacturing, and biomedical research, the ability to perform accurate measurements is key to a variety of studies. Whilst it is sufficient ...

You don’t have to miss the innovation because you missed the conference. In this ASHG25 workshop replay, we unveil a new automated microarray workflow that enables sample-to-report in ...

Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...

As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...